Medical Dialogues
  • Dermatology
Sign in Signup
This site is intended for healthcare professionals only
Sign in Signup
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
Medical Dialogues
  • Medical News
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Medical Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
  • MDTV
      • Anesthesia
      • CTVS
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • Diet and nutrition
      • ENT
      • Gastroenterology
      • Health Dialogues
      • Health News today
      • Health Shorts
      • Health Updates
      • Health video of the day
      • Laboratory Medicine
      • Latest Videos
      • Latest Webinars
      • MD shorts
      • Medical News Today
      • Medical Updates
      • Medical Video of the day
      • Medicine
      • Nephrology
      • Neurology and Neurosurgery
      • Obstetrics and Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics & Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Top Videos
      • Urology
This site is intended for healthcare professionals only
Sign InRegister
Medical Dialogues
Sign inRegister
  • Home
  • Medical news
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Medical Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
  • Case of the Day
  • Editorial
  • Home
  • Medicine
  • Medicine News
  • Low-dose hydroxyurea...

Low-dose hydroxyurea therapy may prevent stroke in children with sickle-cell anemia: Lancet

Medical Dialogues Editorial TeamBy Medical Dialogues Editorial TeamPublished On 2022-01-21T09:00:27+05:30  |  Updated On 2022-01-21T09:00:54+05:30
Low-dose hydroxyurea therapy may prevent stroke in children with sickle-cell anemia: Lancet

Kano, Nigeria: A new study found that as compared to low-dose hydroxyurea therapy, moderate-dose hydroxyurea therapy showed no change in stroke incidence rate in children with sickle cell anemia. Secondary analyses, however, show that the moderate-dose group may have a reduced incidence rate of all-cause hospitalizations. The findings, published in The Lancet Haematology, provide...

Kano, Nigeria: A new study found that as compared to low-dose hydroxyurea therapy, moderate-dose hydroxyurea therapy showed no change in stroke incidence rate in children with sickle cell anemia. Secondary analyses, however, show that the moderate-dose group may have a reduced incidence rate of all-cause hospitalizations.

The findings, published in The Lancet Haematology, provide an evidence-based guideline for the use of low-dose hydroxyurea therapy for primary stroke prevention in children with sickle cell anemia. 

Standard care for primary stroke prevention in children with sickle cell anemia and abnormal transcranial Doppler velocities results in a 92% relative risk reduction of strokes in high-income countries but warrant initial monthly blood transfusion. In Africa, regular blood transfusion is not feasible for most children. 

Given the above background, Shehu U Abdullahi and the team conducted the study with the objective to test in children with aberrant transcranial Doppler velocities, starting with moderate-dose hydroxyurea rather than a low-dose reduces the risk of stroke. 

SPRING is a phase 3 study of children aged 5–12 years with sickle cell anemia and aberrant transcranial Doppler velocities that is being done at three teaching hospitals in Nigeria. We employed a permuted block allocation approach with four block sizes, stratified by sex and site, for randomization. Except for the pharmacists and statisticians, the allocation was kept secret. Participants were randomly randomized to receive either low-dose (10 mg/kg per day) or moderate-dose (20 mg/kg per day) oral hydroxyurea once daily, with monthly clinical evaluation and laboratory monitoring. The primary outcome was a centrally assessed first stroke or transient ischemic attack. The secondary outcome was hospitalization for any reason. For data analysis, we employed the intention-to-treat population.

The results of this work stated as follow:

1. Between August 2, 2016, and June 14, 2018, 220 people were assigned at random and tracked for a median of 24 years.

2. All of the participants were Nigerians from the following ethnic groups: 179 persons (82%) identified as Hausa, 25 (11%) as Fulani, and 16 (7%) as another ethnicity.

3. Three (3%) of 109 participants in the low-dose hydroxyurea group had strokes, with an incidence rate of 119 per 100 person-years, while five (5%) of 111 in the moderate-dose hydroxyurea group had strokes, with an incidence rate of 192 per 100 person-years.

4. The incidence rate ratio of hospitalization for any cause was 171, with the low-dose group having greater incidence rates per 100 person-years than the moderate-dose group. No participant's hydroxyurea medication was discontinued due to myelosuppression.

In conclusion, these findings give an evidence-based recommendation for low-dose hydroxyurea treatment in children with sickle cell anemia who are at risk of stroke.

Reference:

Abdullahi, S. U., Jibir, B. W., Bello-Manga, H., Gambo, S., Inuwa, H., Tijjani, A. G., Idris, N., Galadanci, A., Hikima, M. S., Galadanci, N., Borodo, A., Tabari, A. M., Haliru, L., Suleiman, A., Ibrahim, J., Greene, B. C., Ghafuri, D. L., Rodeghier, M., Slaughter, J. C., … DeBaun, M. R. (2022). Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. In The Lancet Haematology (Vol. 9, Issue 1, pp. e26–e37). Elsevier BV. https://doi.org/10.1016/s2352-3026(21)00368-9

The Lancet Haematology hydroxyurea treatment sickle cell anemia stroke 
Source : The Lancet Haematology
Medical Dialogues Editorial Team
Medical Dialogues Editorial Team

    Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable  connection

    Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Review: Efficacy of Antiviral Agents Against  Omicron Subvariant BA.2

    Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

    Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

    View All

    Journal Club Today

    Genes to predict arthritis treatment response – Pave the way for future drug development

    Genes to predict arthritis treatment response – Pave the way for future drug development

    View All

    Health News Today

    Health Bulletin 24/May/2022

    Health Bulletin 24/May/2022

    View All
    © 2019 All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X